Akelos Inc. is a biopharmaceutical clinical company based in New York, NY, that is dedicated to developing innovative non-narcotic drugs for the treatment of neuropathic pain. With a focus on addressing unmet needs in the field, Akelos aims to provide safe and effective alternatives to opioids for patients suffering from chronic pain. Their research-based approach and collaboration with leading universities have resulted in the development of novel compounds that selectively inhibit pain-inducing channels, offering potential relief for millions of individuals worldwide.
Driven by a team of experienced professionals and scientific advisors, including Dr. Steven Fox, the founder and chairman of Akelos Inc., the company is committed to advancing medical research and finding opioid alternatives. With a growing market for neuropathic pain treatments and an urgent need to combat the opioid crisis, Akelos is at the forefront of developing groundbreaking solutions that have the potential to transform the way chronic pain is managed.
Generated from the website